Equities

Cynata Therapeutics Ltd

Cynata Therapeutics Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.215
  • Today's Change0.00 / 0.00%
  • Shares traded33.00
  • 1 Year change+72.00%
  • Beta0.8326
Data delayed at least 20 minutes, as of Nov 22 2024 02:57 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Friday, Cynata Therapeutics Ltd (CYP:ASX) closed at 0.215, 104.76% above the 52 week low of 0.105 set on Nov 27, 2023.
52-week range
Today
0.105Nov 27 20230.345May 30 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.215
High0.215
Low0.215
Bid0.21
Offer0.215
Previous close0.215
Average volume103.46k
Shares outstanding180.68m
Free float152.97m
P/E (TTM)--
Market cap38.85m AUD
EPS (TTM)-0.0543
AUD
Data delayed at least 20 minutes, as of Nov 22 2024 02:57 GMT.
More ▼

Events & Activity

  • CYP:ASX price moved over -2.04% to 0.24
  • CYP:ASX price falls below 200-day moving average to 0.225 at 21:34 GMT
  • CYP:ASX trading volume exceeds daily average by +26.40%
  • CYP:ASX price falls below 50-day moving average to 0.225 at 21:34 GMT
  • CYP:ASX price falls below 15-day moving average to 0.23 at 21:34 GMT
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.